September 4, 2012: Abcam is pleased to announce that following the completion of the acquisition of Epitomics, customers in Europe are now able to purchase Epitomics’ line of high quality RabMAbs® (Rabbit Monoclonal Antibodies) directly from our website.
RabMAbs® provide the combined benefits of superior antigen recognition of the rabbit immune system with the specificity and consistency of a monoclonal antibody, bringing you the highest quality antibody possible.
This move will enhance the service and support for our European customers who will now be able to receive Epitomics research products in a much shorter time frame than previously possible. Most European countries will now receive Epitomics research products via Abcam’s next day delivery service. Abcam’s multi-lingual technical support teams will also be available to answer questions regarding Epitomics products.
Epitomics products can be found directly on Abcam’s website or on Epitomics’ website. Customers in Europe wishing to place orders for Epitomics research products will be able to purchase directly with Abcam.
For a complete list of countries where Epitomics research products can be ordered from and for further details, please visit Epitomics or Abcam. Please note that Epitomics IVD products will continue to be sold through Epitomics existing distribution network.
The acquisition of Epitomics, Inc. now known as Epitomics – an Abcam Company, extends Abcam’s product portfolio, including RabMAbs® research antibodies, EP Clone antibodies for Immunohistochemistry (In Vitro Diagnostics Range) and Custom Antibody Development Services, in line with Abcam’s vision of becoming the world’s leading supplier of life science research tools.
Epitomics, Inc. is a biotechnology company dedicated to developing breakthrough rabbit monoclonal antibody technology for research and diagnostic applications. The Company’s core technology is its unique and proprietary RabMAbs® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays.
Epitomics, Inc. was founded in 2001, headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People’s Republic of China.
Epitomics, Inc. is now known as Epitomics – an Abcam Company.